stockrowAlvotech (ALVO) vs Harrow, Inc. (HROW)
- Alvotech ALVO 4.85 +6.59%
- Harrow, Inc. HROW 26.72 +2.61%
Alvotech and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $976.2M — 1.8× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 21.1%. Harrow, Inc. has the higher net margin (−13.5% vs −101.1%) and the lower return on invested capital (−0.77% vs 0.00%). Across the 16 metrics below, Harrow, Inc. leads on 9 and Alvotech on 7.
Valuation
Profitability
| Metric | ALVO | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 73.28% | 53.51% |
| Operating margin | (42.43%) | (1.00%) | 0.00% |
| Net margin | (101.05%) | (13.51%) | (2.45%) |
| Free cash flow margin | 0.00% | (4.75%) | 0.00% |
| Return on equity | 0.00% | (116.07%) | (0.80%) |
| Return on assets | 0.00% | (9.77%) | (1.67%) |
| Return on invested capital | 0.00% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack